Safety of recombinant activated factor VII in randomized clinical trials.
作者信息
Arellano-Rodrigo Eduardo
出版信息
N Engl J Med. 2011 Feb 10;364(6):574-5; author reply 575-6. doi: 10.1056/NEJMc1013591.
PMID:21306249
Abstract
摘要
相似文献
1
Safety of recombinant activated factor VII in randomized clinical trials.重组活化凝血因子VII在随机临床试验中的安全性。
N Engl J Med. 2011 Feb 10;364(6):574-5; author reply 575-6. doi: 10.1056/NEJMc1013591.
2
Safety of recombinant activated factor VII in randomized clinical trials.重组活化凝血因子VII在随机临床试验中的安全性。
N Engl J Med. 2011 Feb 10;364(6):575; author reply 575-6. doi: 10.1056/NEJMc1013591.
3
Safety of recombinant activated factor VII in randomized clinical trials.重组活化凝血因子VII在随机临床试验中的安全性。
N Engl J Med. 2011 Feb 10;364(6):574; author reply 575-6. doi: 10.1056/NEJMc1013591.
4
Off-label use of recombinant activated factor VII--safe or not safe?重组活化凝血因子 VII 的非标签使用——安全与否？
N Engl J Med. 2010 Nov 4;363(19):1853-4. doi: 10.1056/NEJMe1008857.
5
Safety of recombinant activated factor VII in randomized clinical trials.重组活化凝血因子VII在随机临床试验中的安全性。
N Engl J Med. 2011 Feb 10;364(6):575; author reply 575-6. doi: 10.1056/NEJMc1013591.
6
Safety of recombinant activated factor VII in randomized clinical trials.重组活化因子 VII 在随机临床试验中的安全性。
N Engl J Med. 2010 Nov 4;363(19):1791-800. doi: 10.1056/NEJMoa1006221.
7
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.系统评价：院内使用重组 VII 因子治疗超适应证的获益和危害。
Ann Intern Med. 2011 Apr 19;154(8):529-40. doi: 10.7326/0003-4819-154-8-201104190-00004.
8
Off-label use of recombinant factor VIIa.重组凝血因子VIIa的超说明书用药
Ann Intern Med. 2011 Sep 6;155(5):337-8; author reply 338-9. doi: 10.7326/0003-4819-155-5-201109060-00021.
9
Off-label use of recombinant factor VIIa.重组凝血因子VIIa的非标签使用。
Ann Intern Med. 2011 Sep 6;155(5):337; author reply 338-9. doi: 10.7326/0003-4819-155-5-201109060-00020.
10
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.诺其®用于心脏手术出血后的凝血变化。
Asian Cardiovasc Thorac Ann. 2017 Feb;25(2):99-104. doi: 10.1177/0218492317689901. Epub 2017 Jan 23.
引用本文的文献
1
Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases.重组人活化凝血因子 VII 用于肝病患者上消化道出血的治疗
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD004887. doi: 10.1002/14651858.CD004887.pub3.
Zotero 插件